Cargando…
Treatment Landscape for Metastatic Castrate-Sensitive Prostate Cancer: A Review
With the advent of new therapeutic modalities, management of metastatic castrate-sensitive prostate cancer (mCSPC) has been in flux. From androgen-deprivation therapy to docetaxel to androgen receptor–signaling inhibitors, each agent has heralded a new treatment paradigm. As such, the optimal first-...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655601/ https://www.ncbi.nlm.nih.gov/pubmed/38025805 http://dx.doi.org/10.2147/RRU.S398129 |